Our patented MJR-technology can be applied to different types of active pharmaceutical ingredients (APIs) for the production of nanoparticles and drug delivery systems.
The MJR-Technology can be applied to different types of active pharmaceutical ingredients (APIs):
leon-nanodrugs can produce the following nanoparticles and drug delivery systems under GMP conditions:

leon-nanodrugs’ nanoparticle formulations can be offered in various application forms, depending on the specific API, the therapeutic indication and specific therapeutical demands. We can provide immediate release formulations as well as sustained release formulations of different application forms, such as: